LC
ETON icon

Lindbrook Capital’s Eton Pharmaceutcials ETON Stock Holding History

Lindbrook Capital’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4
Closed -$13 – 2856
2024
Q2 		$13 Hold
4
– – ﹤0.01% 2753
2024
Q1 		$15 Hold
4
– – ﹤0.01% 2640
2023
Q4 		$18 Hold
4
– – ﹤0.01% 2681
2023
Q3 		$17 Hold
4
– – ﹤0.01% 2674
2023
Q2 		$14 Hold
4
– – ﹤0.01% 2698
2023
Q1 		$15 Hold
4
– – ﹤0.01% 2764
2022
Q4 		$11 Hold
4
– – ﹤0.01% 2816
2022
Q3 		$0 Hold
4
– – ﹤0.01% 2700
2022
Q2 		$0 Hold
4
– – ﹤0.01% 2560
2022
Q1 		$0 Hold
4
– – ﹤0.01% 2513
2021
Q4 		$0 Hold
4
– – ﹤0.01% 2112
2021
Q3 		$0 Hold
4
– – ﹤0.01% 1890
2021
Q2 		$0 Buy
+4
New +$30 ﹤0.01% 1935

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.43M AUM 17.52% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lindbrook Capital's ETON Position: Q3 2024 in Review

Lindbrook Capital sold out of Eton Pharmaceutcials (ETON) in Q3 2024, closing a stake of 4 shares — an estimated $13 sold.

Lindbrook Capital first reported a position in ETON in Q2 2021 and held it in 13 quarters. The position peaked at $18 in Q4 2023. 48 funds tracked by Wall St. Rank hold ETON as of Q3 2024.

  • Lindbrook Capital reported no remaining Eton Pharmaceutcials position as of Q3 2024 after selling out during the quarter.
  • Lindbrook Capital sold 4 Eton Pharmaceutcials shares in Q3 2024, an estimated $13.
  • Lindbrook Capital first reported a position in Eton Pharmaceutcials in Q2 2021 and held it in 13 quarters.
  • Lindbrook Capital's Eton Pharmaceutcials position peaked at $18 in Q4 2023.
  • 48 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2024.

Based on Lindbrook Capital's 13F filing for Q3 2024, filed 1 Nov 2024.